Preço das Ações
785.51
Mudança Diária
18.88 2.46%
Mensal
-3.29%
Anual
10.64%
Q1 Previsão
761.39




Lucro Bruto Sobre Vendas Alterar Data
AbbVie USD 10.47B 605M 2025-09
Agios Pharmaceuticals USD 11.2M 448K 2025-09
Alnylam Pharmaceuticals USD 1.05B 418.14M 2025-09
Amgen USD 6.48B 307M 2025-09
Astellas Pharma JPY 456.81B 38.02B 2025-12
AstraZeneca USD 12.39B 406M 2025-09
Biogen USD 1.65B 34.6M 2025-12
BioMarin Pharmaceutical USD 631.2M 39.27M 2025-09
Bristol-Myers Squibb USD 8.79B 110M 2025-09
Eli Lilly USD 14.59B 1.48B 2025-09
Gilead Sciences USD 5.58B 453M 2025-06
GlaxoSmithKline GBP 6.18B 106M 2025-12
Incyte USD 1.27B 130.22M 2025-09
Ionis Pharmaceuticals USD 155M 293M 2025-09
J&J USD 16.6B 118M 2025-12
Kyowa Hakko Kirin JPY 90.6B 1.95B 2025-09
Merck USD 13.42B 431M 2025-09
Moderna USD 809M 791M 2025-09
Neurocrine Biosciences USD 780.9M 104.7M 2025-09
Novartis USD 10.82B 695M 2025-09
Novartis USD 10.82B 694M 2025-09
Pfizer USD 3.54B 7.61B 2025-09
Regeneron Pharmaceuticals USD 3.3B 67M 2025-12
Roche Holding CHF 22.09B 10.04B 2025-12
Sanofi EUR 8.45B 3.02B 2025-12
Sarepta Therapeutics USD 247.9M 209.96M 2025-09
Teva Pharmaceutical Industries USD 2.66B 351M 2025-12
Ultragenyx Pharmaceutical USD 131.94M 11.55M 2025-09
United Therapeutics USD 602.1M 108.9M 2025-09
Vertex Pharmaceuticals USD 2.66B 104.4M 2025-09


Regeneron Pharmaceuticals Lucro Bruto Sobre Vendas - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - Feb 2026.